Ablation therapy and implantable device based approaches for supraventricular arrhythmias

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Supraventricular tachycardia is a commonly encountered condition. Atrial fibrillation has a particularly high incidence in the aging population of industrialized nations. While medical therapy was the mainstay of treatment for several decades, improvements in invasive catheter ablation have made this the preferred therapy in many cases. With an impetus provided by the very high incidence, prevalence, and clinical burden of atrial fibrillation, techniques to improve the safety and efficacy of atrial fibrillation ablation have progressed rapidly over the last two decades. This chapter initially outlines supraventricular tachycardia mechanisms, diagnostic testing, and the therapies. It then focuses in depth on emerging technologies in invasive management of atrial fibrillation.

Original languageEnglish (US)
Title of host publicationEmerging Technologies for Heart Diseases
Subtitle of host publicationVolume 2: Treatments for Myocardial Ischemia and Arrhythmias
PublisherElsevier
Pages741-760
Number of pages20
ISBN (Electronic)9780128137048
DOIs
StatePublished - Jan 1 2020
Externally publishedYes

Keywords

  • Ablation
  • Atrial fibrillation
  • Mapping
  • Pulmonary veins
  • Supraventricular tachycardia

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Ablation therapy and implantable device based approaches for supraventricular arrhythmias'. Together they form a unique fingerprint.

Cite this